Literature DB >> 16410127

The value of surgery in directing therapy for patients with Wilms' tumor with pulmonary disease. A report from the National Wilms' Tumor Study Group (National Wilms' Tumor Study 5).

Peter F Ehrlich1, Thomas E Hamilton, Paul Grundy, Michael Ritchey, Gerald Haase, Robert C Shamberger.   

Abstract

BACKGROUND/
PURPOSE: Computed tomography (CT) of the chest with its increased sensitivity frequently identifies lesions not visible on chest radiograph. Treatment of such lesions is controversial. A recent review suggests that patients with Wilms' tumor with pulmonary lesions detected only by CT, who were treated with dactinomycin and vincristine, have an inferior outcome compared with those who also received pulmonary radiation therapy (RT) and doxorubicin. It is important to determine if these small lesions seen only on CT represent metastatic disease and whether patients with these lesions require RT and/or doxorubicin for optimal outcome.
METHODS: Patients with Wilms' tumor with lung metastasis, registered on National Wilms' Tumor Study 5, were reviewed, and those with CT-only lesions who had a radiology and surgical checklist submitted were identified. The treatment regimens of these patients and the histological findings of the pulmonary lesions are presented. We analyzed the pathological findings by whether the patients had single or multiple lesions.
RESULTS: Of 2498 patients registered on National Wilms' Tumor Study 5, 252 had pulmonary metastases. Of these patients, 129 (5.2%) had CT-only lesions (<1 cm). Forty-two of these patients (20 boys and 22 girls) underwent lung biopsy at the discretion of the attending physicians. The local tumor stages in these patients were stage I (7%), II (34%), and III (59%). The treatment stages in these patients were stage I (n = 3, 2 drugs), II (n = 3, 2 drugs), III (n = 12, 3 drugs); and IV (n = 24, 3 drugs + RT). There were 16 patients with isolated lung lesions and 26 with multiple lesions, average size 5.8 +/- 0.5 mm. Of 16 isolated lesions, 13 patients (82%) and 69% (18/26) with multiple lesions had tumor on biopsy. Of the 24 who received RT, 8 had a negative biopsy and, thus, may not have needed the RT. Five of 6 treated with just 2 drugs may have been undertreated. Nine of 12 treated with 3 drugs had tumor on biopsy.
CONCLUSIONS: Computed tomography-only pulmonary lesions are not invariably tumor, demonstrating the need for histopathological confirmation. Biopsy remains critical until radiographic techniques allow differentiation between benign and malignant lesions to optimally direct therapy.

Entities:  

Mesh:

Year:  2006        PMID: 16410127     DOI: 10.1016/j.jpedsurg.2005.10.020

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  16 in total

1.  Considerations in the Diagnosis and Management of Pediatric Patients With Favorable Histology Wilms Tumor Who Present With Only Pulmonary Nodules.

Authors:  Daniel M Green
Journal:  Pediatr Blood Cancer       Date:  2015-12-02       Impact factor: 3.167

Review 2.  Staging of common paediatric tumours.

Authors:  Hervé J Brisse
Journal:  Pediatr Radiol       Date:  2009-06

3.  Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study.

Authors:  David B Dix; Nita L Seibel; Yueh-Yun Chi; Geetika Khanna; Eric Gratias; James R Anderson; Elizabeth A Mullen; James I Geller; John A Kalapurakal; Arnold C Paulino; Elizabeth J Perlman; Peter F Ehrlich; Marcio Malogolowkin; Julie M Gastier-Foster; Elizabeth Wagner; Paul E Grundy; Conrad V Fernandez; Jeffrey S Dome
Journal:  J Clin Oncol       Date:  2018-04-16       Impact factor: 44.544

4.  FDG positron emission tomography/computed tomography studies of Wilms' tumor.

Authors:  A K M Moinul Hossain; Barry L Shulkin; Michael J Gelfand; Humayun Bashir; Najat C Daw; Susan E Sharp; Helen R Nadel; Jeffrey S Dome
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-04       Impact factor: 9.236

5.  Clinical significance of pulmonary nodules detected by CT and Not CXR in patients treated for favorable histology Wilms tumor on national Wilms tumor studies-4 and -5: a report from the Children's Oncology Group.

Authors:  Paul E Grundy; Daniel M Green; Astrid C Dirks; Andrea E Berendt; Norman E Breslow; James R Anderson; Jeffrey S Dome
Journal:  Pediatr Blood Cancer       Date:  2012-03-15       Impact factor: 3.167

6.  Reply to D.M. Green.

Authors:  David B Dix; Conrad V Fernandez; Yueh-Yun Chi; Lindsay A Renfro; Jeffrey S Dome Md
Journal:  J Clin Oncol       Date:  2020-01-17       Impact factor: 44.544

Review 7.  Metastasectomy in pediatric patients: indications, technical tips and outcomes.

Authors:  Paolo Scanagatta; Lara Girelli
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

Review 8.  Imaging in unilateral Wilms tumour.

Authors:  Hervé J Brisse; Anne M Smets; Sue C Kaste; Catherine M Owens
Journal:  Pediatr Radiol       Date:  2007-11-16

Review 9.  Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration.

Authors:  Jeffrey S Dome; Norbert Graf; James I Geller; Conrad V Fernandez; Elizabeth A Mullen; Filippo Spreafico; Marry Van den Heuvel-Eibrink; Kathy Pritchard-Jones
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

10.  Wilms' tumor: An update.

Authors:  Hemant B Tongaonkar; Sajid S Qureshi; Purna A Kurkure; Mary-Ann A Muckaden; Brijesh Arora; Thyavihalli B Yuvaraja
Journal:  Indian J Urol       Date:  2007-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.